Author:
Roy V.,LaPlant B.R.,Gross G.G.,Bane C.L.,Palmieri F.M.
Funder
Public Health Service
National Cancer Institute, Department of Heath and Human Services
Reference21 articles.
1. Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications;Sparreboom;Cancer Res,1999
2. Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer;John;Am J Physiol Lung Cell Mol Physiol,2003
3. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer;Gradishar;J Clin Oncol,2005
4. Long term disease control in taxane-refractory metastatic breast cancer treated with nab paclitaxel;Blum;J Clin Oncol,2004
5. A randomized phase 2 trial of qw or q3w ABI-007 (ABX) vs. q3W solvent-based docetaxel (TXT) as first-line therapy in metastatic breast cancer (MBC);Gradishar;Breast Cancer Res Treat,2006
Cited by
122 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献